Susquehanna International Group
PLRX icon

Susquehanna International Group’s Pliant Therapeutics PLRX Stock Holding History

Susquehanna International Group’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$66.7K Buy
52,956
+18,755
+55% +$23.7K ﹤0.01% 12537
2025
Q4 		$41.7K Sell
34,201
-39,753
-54% -$59.7K ﹤0.01% 11815
2025
Q3 		$109K Sell
73,954
-96,032
-56% -$147K ﹤0.01% 11510
2025
Q2 		$197K Buy
169,986
+73,519
+76% +$104K ﹤0.01% 11231
2025
Q1 		$130K Buy
96,467
+27,893
+41% +$169K ﹤0.01% 11335
2024
Q4 		$903K Buy
68,574
+21,936
+47% +$299K ﹤0.01% 7214
2024
Q3 		$523K Buy
46,638
+17,202
+58% +$215K ﹤0.01% 8361
2024
Q2 		$316K Buy
29,436
+6,691
+29% +$86.3K ﹤0.01% 9328
2024
Q1 		$339K Sell
22,745
-54,862
-71% -$905K ﹤0.01% 9433
2023
Q4 		$1.41M Sell
77,607
-66,901
-46% -$1.02M ﹤0.01% 6150
2023
Q3 		$2.51M Buy
144,508
+85,624
+145% +$1.48M ﹤0.01% 4698
2023
Q2 		$1.07M Sell
58,884
-538,987
-90% -$12.8M ﹤0.01% 6530
2023
Q1 		$15.9M Buy
597,871
+172,975
+41% +$4.92M ﹤0.01% 1926
2022
Q4 		$8.21M Buy
424,896
+362,799
+584% +$7.58M ﹤0.01% 2529
2022
Q3 		$1.3M Buy
62,097
+12,305
+25% +$235K ﹤0.01% 5961
2022
Q2 		$399K Buy
+49,792
New +$319K ﹤0.01% 8818
2022
Q1 		– Sell
-29,103
Closed -$393K – 13746
2021
Q4 		$393K Buy
29,103
+11,955
+70% +$190K ﹤0.01% 9830
2021
Q3 		$289K Buy
17,148
+10,189
+146% +$216K ﹤0.01% 10685
2021
Q2 		$203K Sell
6,959
-18,639
-73% -$580K ﹤0.01% 11572
2021
Q1 		$1.01M Buy
25,598
+11,044
+76% +$359K ﹤0.01% 7724
2020
Q4 		$331K Sell
14,554
-23,113
-61% -$580K ﹤0.01% 9078
2020
Q3 		$853K Buy
+37,667
New +$941K ﹤0.01% 6504

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Susquehanna International Group's PLRX Position: Q1 2026 in Review

Susquehanna International Group increased its Pliant Therapeutics (PLRX) stake by 55% in Q1 2026, buying an estimated $23.7K and bringing the position to 52,956 shares worth $66.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12537.

Susquehanna International Group first reported a position in PLRX in Q3 2020 and has held it in 22 quarters since. The position peaked at $15.9M in Q1 2023. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Susquehanna International Group held 52,956 shares of Pliant Therapeutics worth $66.7K as of Q1 2026.
  • Susquehanna International Group bought 18,755 Pliant Therapeutics shares in Q1 2026, an estimated $23.7K.
  • Pliant Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12537 holding.
  • Susquehanna International Group first reported a position in Pliant Therapeutics in Q3 2020 and has held it in 22 quarters since.
  • Susquehanna International Group's Pliant Therapeutics position peaked at $15.9M in Q1 2023.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.